PRJNA316321
FDA/CDC Isolate Bank Genome Sequencing
The AR Isolate Bank is a centralized repository of microbial pathogens with well-characterized resistance profiles that are assembled by CDC in collaboration with the Food and Drug Administration (FDA). The AR Bank is available to support and advance development of diagnostic devices and antimicrobial drug products. The AR Isolate Bank also supports the National Action Plan for Combating Antibiotic Resistance Bacteria by advancing the development of diagnostic tests to identify and characterize resistant bacteria, and by accelerating research and development for new antibiotics.The AR Isolate Bank includes collections of bacterial pathogens that are associated with known or emerging resistance mechanisms. Since its launch in July 2015, the AR Bank continues to grow and will eventually include genera and species such as Enterobacteriaceae, Pseudomonas aeruginosa, Staphylococcus, Enterococcus, Streptococcus, Salmonella, and Neisseria gonorrhoeae.Each pathogen listed on this web site includes information regarding its susceptibility and/or resistance profile(s), known resistance biomarkers, isolate characteristics, and associated data in PDF.Use this web site to search through pathogen panels, find additional information about the available isolates, and find procedures for requesting panels.